Ron Martell
CIK: 0001177079
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Jasper Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026JSPR
Jasper Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
234K shares- - Sep 22, 2025JSPR
Jasper Therapeutics, Inc.
Purchase(P)Direct41K shares at avg. $2.43$100K - Jun 4, 2025JSPR
Jasper Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
234K shares- - Feb 13, 2025JSPR
Jasper Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
130K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | JSPR Jasper Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 234,000 | - | - | Direct |
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | Purchase(P) | 41,000 | $2.43 | $99,630 | Direct |
| Jun 4, 2025 | JSPR Jasper Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 234,000 | - | - | Direct |
| Feb 13, 2025 | JSPR Jasper Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 130,000 | - | - | Direct |
1-4 of 4 transactions
About MARTELL RON
MARTELL RON (SEC CIK 0001177079) files insider reports with the SEC as President, CEO and Director of Jasper Therapeutics, Inc. (JSPR).
Signal8 holds 4 ownership filings by MARTELL RON, all Form 4s, filed between Feb 18, 2025 and Jan 5, 2026. Those filings report 4 transactions, from Feb 13, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MARTELL RON's filings is in REDWOOD CITY, CA.
Recent filings by MARTELL RON
Other insiders filing for Jasper Therapeutics, Inc. (JSPR)
- WIGGANS THOMAS G, Director
- Lucas Svetlana, Director
- Crutcher Patrick J, Director
- EMSTER KURT VON, Director
- Shizuru Judith Anne, Director
- Keenan Greg, Chief Medical Officer